English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduExposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status, a new study finds. The results will be presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Tag: Thyroid
Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions
Most patients with thyroid eye disease treated with teprotumumab didn’t require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass., and published in the journal Thyroid.
People with hypothyroidism and type D personality may be more likely to experience poor treatment outcomes
New research published in The Journal of Clinical Endocrinology & Metabolism finds a high prevalence of type D personality among people with hypothyroidism.
Courtney Gibson, MD, MS, FACS, in honor of Thyroid Cancer Awareness Month
What advances have made the biggest impact in the treatment of patients with thyroid cancer over the last five years, and what is the outlook for thyroid cancer in the next five years? Molecular testing (MT) to examine somatic changes has become an important adjunct in the diagnosis and treatment of many cancers.
American Thyroid Association® Announces Award Recipients
American Thyroid Association awards honor clinicians, academicians with outstanding contributions to advancing thyroid research and care.
Radioactive iodine or surgery associated with increased survival in hyperthyroidism
Hyperthyroidism treatment like radioactive iodine or surgery was associated with a decreased risk for death, according to research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago.
Growing number of hypothyroidism patients receiving treatment other than levothyroxine
The use of thyroid hormones other than the commonly prescribed hormone medicine levothyroxine to treat hypothyroidism, or underactive thyroid, is increasing, according to a study being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Exposure to dioxins can worsen thyroid function
Exposure to dioxins can negatively impact thyroid function, according to a study presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Thyroid Problems Linked to Increased Risk of Dementia
Older people with hypothyroidism, also called underactive thyroid, may be at increased risk of developing dementia, according to a study published in the July 6, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology. The risk of developing dementia was even higher for people whose thyroid condition required thyroid hormone replacement medication.
text
text
AI can be used to identify benign thyroid nodules and reduce unnecessary biopsies
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Drinking coffee does not hinder the absorption of liquid thyroid medication
A new study conducted by Vertice Pharma confirms the absorption of an oral levothyroxine sodium solution (Thyquidity® 100g/ 5mL) was not affected by consuming coffee 5 minutes after the dose, according to research being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism,
according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.
Thyroid hormone replacement undertreatment linked to worse hospital outcomes
Undertreatment with thyroid hormone replacement can put patients with hypothyroidism at risk for worse hospital outcomes, including longer length of stay and higher rates of readmission, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism.
American Thyroid Association Announces Award Recipients
Esteemed clinicians and researchers recognized for their contributions to American Thyroid Association, thyroid cancer and thyroid disease research.
ATA Announces Women Advancing Thyroid Research Award Recipients
The American Thyroid Association (ATA) celebrates the recipients of the Women Advancing Thyroid Research Award. This award recognizes and honors the work of young women that are leading outstanding thyroid research.
COVID-19 can cause atypical thyroid inflammation
Some patients with moderate to severe COVID-19 disease seem to experience inflammation of the thyroid gland that is different from thyroid inflammation caused by other viruses, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine
Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to replace the body’s two main thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Results of their new randomized clinical study are being presented at ENDO 2021, the Endocrine Society’s annual meeting.
Nearly one-third of older thyroid patients take medications that interfere with thyroid function tests
Nearly one-third of adults age 65 and older who take thyroid hormone also take medications that are known to interfere with thyroid function tests, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
New Guidelines for Anaplastic Thyroid Cancer
American Thyroid Association releases new guidelines for the diagnosis, evaluation, and treatment of anaplastic thyroid cancer.
Discovery Illuminates How Thyroid Hormone ‘Dims’ Metabolism
Basic biology finding on thyroid hormone function could lead to new treatments for obesity, diabetes and related disorders
Singing a Tumor Test Song
Singing may be the next-generation, noninvasive approach to determining the health of a patient’s thyroid. When a person sings, the vibrations create waves in the tissue near the vocal tract called shear waves. If a tumor is present in the thyroid, the elasticity of its surrounding tissue increases, stiffening, and causing the shear waves to accelerate. Using ultrasound imaging to measure these waves, researchers can determine the elasticity of the thyroid tissue. They demonstrate the technique in Applied Physics Letters.
American Thyroid Association to Host Patient Education Forum
American Thyroid Association to host ATA Alliance for Thyroid Patient Education Health Forum on Saturday, November 14, 2020 from noon – 1:15pm EST. Clinicians, Patient Advocates, Patients, and Families invited to participate.
A quest for excellence
Ivan Piñón, MD, once thought his future would lead to the lab bench. But a long career practicing as an endocrinologist has led him to the UNM Comprehensive Cancer Center to serve as a crucial part of the effort to build a thyroid and parathyroid center of excellence.
Mild thyroid dysfunction affects one in five women with a history of miscarriage or subfertility
Mild thyroid abnormalities affect up to one in five women with a history of miscarriage or subfertility which is a prolonged time span of trying to become pregnant that hasn’t reached a year, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Patients with COVID-19 may develop thyroid infection
COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism.
NEW EXECUTIVE DIRECTOR ANNOUNCED FOR THE AMERICAN THYROID ASSOCIATION
The new Executive Director replaces a legacy leader who has served the ATA for 24 years.
First FDA-approved drug for thyroid eye disease effective regardless of age, gender
Teprotumumab, the first FDA-approved medicine for thyroid eye disease, provides significant improvement in eye bulging, regardless of patient gender, age or smoking status, according to a study accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Cancer treatment with immune checkpoint inhibitors may lead to thyroid dysfunction
Thyroid dysfunction following cancer treatment with new treatments called immune checkpoint inhibitors is more common than previously thought, according to research that was accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and will be published in a special supplemental section of the Journal of the Endocrine Society.
Survey finds physicians struggle to communicate positive prognosis to thyroid cancer patients
Despite excellent prognosis with most thyroid cancers, many newly diagnosed patients have cancer-related worry, and physicians vary in their responses to patients’ worry, according to new research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Hypothyroidism patients cite effectiveness in choosing alternative to standard therapy
Three in four hypothyroidism patients who chose desiccated thyroid extract (DTE) over the standard therapy said this option was more effective than other thyroid hormone medications, according to an analysis of comments in online patient forums accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Underactive thyroid more common in people working long hours
Adults who work long hours are more likely to have hypothyroidism, which is an underactive thyroid, according to study results accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Thyroid hormone use may raise death risk in older adults
Thyroid hormone replacement therapy in older adults is associated with a higher risk of death compared with no treatment, a large study finds. The study results were accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.
Virtual ENDO 2020 news conferences to highlight advances in technology, thyroid health
Researchers will discuss how artificial intelligence and drones are being incorporated into health care when they share the latest emerging science during the Endocrine Society’s ENDO 2020 virtual news conferences March 30-31.
Expert Team Tackles Thyroid and Parathyroid Diseases
When the thyroid and parathyroid glands don’t work well, the entire body feels out of balance. To tackle thyroid and parathyroid diseases, Nathan Boyd, MD, recently launched the UNM Thyroid and Parathyroid Surgery Program, housed at the UNM Comprehensive Cancer Center, to offer state-of-the-art treatments for these diseases.
Aggressive features in some small thyroid tumors increase the risk for metastasis
Results from a new large-scale study show that in nearly 20 percent of patients, papillary thyroid tumors less than 1 cm in size had pathological signs of more aggressive disease that increased the risk that these patients might develop distant metastasis.
Guidelines for Thyroid Surgery Published in Annals of Surgery
The first set of comprehensive, evidence-based clinical guidelines for surgical treatment of thyroid disease – developed by an expert panel assembled by the American Association of Endocrine Surgeons (AAES) – was published today by Annals of Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Older adults with hypothyroidism face elevated risk of death
While older adults with hypothyroidism face an elevated risk of death, individuals with subclinical hypothyroidism, a milder form of underactive thyroid, did not face the same risk, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Researchers identify new gene mutation in familial thyroid cancers
Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer.
Thyroid Pathophysiology Medal Awarded to Sissy M. Jhiang, PhD, at American Thyroid Association’s Annual Meeting
November 1, 2019—The American Thyroid Association (ATA) announces with pleasure that the 2019 John B. Stanbury Thyroid Pathophysiology Medal will be awarded to Dr. Sissy M. Jhiang at the ATA Annual Meeting this week. Dr. Jhiang is the Professor of Physiology and Cell Biology at the Ohio State University (OSU), member of the OSU Comprehensive Cancer Center and Graduate Faculty member for multiple graduate programs.
2019 Lewis E. Braverman Distinguished Award to Be Presented to Martha A. Zeiger, MD, at American Thyroid Association’s Annual Meeting
November 2, 2019—The American Thyroid Association (ATA) announces with pleasure that the 2019 Lewis E. Braverman Distinguished Award recipient will be Dr. Martha A. Zeiger, Director of Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.The Braverman Distinguished Award is presented annually to an individual who: demonstrates excellence and passion for mentoring fellows, students, and junior faculty; has a long history of productive thyroid research; and is devoted to the ATA.
2019 Distinguished Service Award to Be Given to Robert C. Smallridge, MD, at American Thyroid Association’s Annual Meeting
November 1, 2019—The American Thyroid Association (ATA) is pleased to announce that the Distinguished Service Award recipient will be Dr. Robert C. Smallridge. He is Professor of Medicine at Mayo Medical School and the Alfred D. and Audrey M. Petersen Professor of Cancer Research. He is a Deputy Director in the Mayo Clinic Cancer Center and has served as the Chair of the Division of Endocrinology, the Director of Research, and as a member of the Board of Governors.
2019 Sidney H. Ingbar Distinguished Lectureship Award to Be Given to Bryan R. Haugen, MD at American Thyroid Association’s Annual Meeting
November 1, 2019—The American Thyroid Association (ATA) is pleased to announce that the 2019 Sidney H. Ingbar Distinguished Lectureship Award recipient will be Dr. Bryan R. Haugen, currently is Professor of Medicine and Pathology at the University of Colorado Denver. He is also Chief of the Division of Endocrinology, Metabolism & Diabetes and Director of the Thyroid Tumor Program and holds the Mary Rossick Kern and Jerome H.